Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
27
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Radovich Peter | Director | 1 | $0 | $0 | 2026-10-20 |
| Azoulay Salomon | Chief Medical Officer | 13 | $0 | $2.74M | 2026-08-04 |
| Smither John W | Chief Financial Officer | 4 | $0 | $0 | 2026-08-03 |
| Hoerter Steven L. | President and CEO, Director | 14 | $265.0K | $0 | 2026-08-03 |
| Ryder Steven | Director | 3 | $0 | $0 | 2026-06-04 |
| Aynechi Tiba | Director | 6 | $12.00M | $0 | 2026-06-04 |
| Stelzer Laurie | Director | 2 | $0 | $0 | 2026-06-04 |
| Pescovitz Ora H. | Director | 4 | $45.3K | $0 | 2026-06-04 |
| Heron Patrick J | Director, 10% Owner | 7 | $10.00M | $0 | 2026-06-04 |
| Mathers Edward T | Director, 10% Owner | 8 | $8.00M | $0 | 2026-06-04 |
| Hawryluk P. Kent | President & CEO | 19 | $1.33M | $17.9K | 2026-05-06 |
| Bartram Richard | Chief Financial Officer | 4 | $0 | $0 | 2026-02-02 |
| FHMLS X, L.P. | 10% Owner | 5 | $22.00M | $0 | 2025-09-26 |
| CORNELIUS JAMES M | Director | 5 | $0 | $0 | 2025-06-05 |
| OrbiMed Genesis GP LLC | Director, 10% Owner | 4 | $2.02M | $0 | 2025-02-18 |
| GORDON CARL L | Director, 10% Owner | 12 | $14.02M | $0 | 2025-02-18 |
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% Owner | 4 | $0 | $0 | 2024-09-16 |
| Yang Rick | 10% Owner | 5 | $8.00M | $0 | 2024-09-16 |
| NEA Partners 17, L.P. | 10% Owner | 5 | $8.00M | $0 | 2024-09-16 |
| Chang Carmen | 10% Owner | 5 | $8.00M | $0 | 2024-09-16 |
| Makhzoumi Mohamad | 10% Owner | 5 | $8.00M | $0 | 2024-09-16 |
| Behbahani Ali | 10% Owner | 5 | $8.00M | $0 | 2024-09-16 |
| Florence Anthony A. Jr. | 10% Owner | 5 | $8.00M | $0 | 2024-09-16 |
| Walker Paul Edward | 10% Owner | 5 | $8.00M | $0 | 2024-09-16 |
| BASKETT FOREST | 10% Owner | 5 | $8.00M | $0 | 2024-09-16 |
| SANDELL SCOTT D | 10% Owner | 5 | $8.00M | $0 | 2024-09-16 |
| ORBIMED ADVISORS LLC | Director, 10% Owner | 7 | $12.00M | $0 | 2024-09-16 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Radovich Peter | Director | A Award deriv | 2026-10-20 | 2026-10-22 | 18,200 | — | $0 | 18,200 | SEC↗ |
| Azoulay Salomon | Chief Medical Officer | S Sale | 2026-08-04 | 2026-08-05 | 370 | $65.77 | $24.3K | 14,399 | SEC↗ |
| Azoulay Salomon | Chief Medical Officer | S Sale | 2026-08-04 | 2026-08-05 | 370 | $65.77 | $24.3K | 14,399 | SEC↗ |
| Hoerter Steven L. | President and CEO | A Award deriv | 2026-08-03 | 2026-08-04 | 331,000 | — | $0 | 331,000 | SEC↗ |
| Smither John W | Chief Financial Officer | A Award deriv | 2026-08-03 | 2026-08-04 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Hoerter Steven L. | President and CEO | A Award | 2026-08-03 | 2026-08-04 | 71,000 | — | $0 | 82,938 | SEC↗ |
| Smither John W | Chief Financial Officer | A Award | 2026-08-03 | 2026-08-04 | 28,000 | — | $0 | 28,000 | SEC↗ |
| Smither John W | Chief Financial Officer | A Award deriv | 2026-08-03 | 2026-08-04 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Smither John W | Chief Financial Officer | A Award | 2026-08-03 | 2026-08-04 | 28,000 | — | $0 | 28,000 | SEC↗ |
| Hoerter Steven L. | President and CEO, Director | A Award deriv | 2026-08-03 | 2026-08-04 | 331,000 | — | $0 | 331,000 | SEC↗ |
| Hoerter Steven L. | President and CEO, Director | A Award | 2026-08-03 | 2026-08-04 | 71,000 | — | $0 | 82,938 | SEC↗ |
| Aynechi Tiba | Director | A Award deriv | 2026-06-04 | 2026-06-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Ryder Steven | Director | A Award deriv | 2026-06-04 | 2026-06-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Hoerter Steven L. | Director | A Award deriv | 2026-06-04 | 2026-06-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Stelzer Laurie | Director | A Award deriv | 2026-06-04 | 2026-06-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Heron Patrick J | Director, 10% Owner | A Award deriv | 2026-06-04 | 2026-06-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Pescovitz Ora H. | Director | A Award deriv | 2026-06-04 | 2026-06-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Mathers Edward T | Director | A Award deriv | 2026-06-04 | 2026-06-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Azoulay Salomon | Chief Medical Officer | M Exercise deriv | 2026-05-08 | 2026-05-11 | 55,000 | — | $0 | 194,540 | SEC↗ |
| Azoulay Salomon | Chief Medical Officer | M Exercise deriv | 2026-05-08 | 2026-05-11 | 15,003 | — | $0 | 30,008 | SEC↗ |
| Azoulay Salomon | Chief Medical Officer | M Exercise | 2026-05-08 | 2026-05-11 | 55,000 | $10.46 | $575.3K | 69,769 | SEC↗ |
| Azoulay Salomon | Chief Medical Officer | S Sale | 2026-05-08 | 2026-05-11 | 15,003 | $38.30 | $574.6K | 14,769 | SEC↗ |
| Azoulay Salomon | Chief Medical Officer | M Exercise | 2026-05-08 | 2026-05-11 | 15,003 | $16.00 | $240.0K | 29,772 | SEC↗ |
| Azoulay Salomon | Chief Medical Officer | S Sale | 2026-05-08 | 2026-05-11 | 55,000 | $38.38 | $2.11M | 14,769 | SEC↗ |
| Hawryluk P. Kent | President & CEO | S Sale | 2026-05-06 | 2026-05-08 | 607 | $29.54 | $17.9K | 727,667 | SEC↗ |
| Azoulay Salomon | Chief Medical Officer | S Sale | 2026-05-06 | 2026-05-08 | 231 | $29.54 | $6.8K | 14,769 | SEC↗ |
| Hoerter Steven L. | Director | A Award deriv | 2026-05-01 | 2026-05-04 | 74,249 | — | $0 | 74,249 | SEC↗ |
| Hoerter Steven L. | Director | A Award | 2026-05-01 | 2026-05-04 | 11,938 | — | $0 | 11,938 | SEC↗ |
| Hawryluk P. Kent | President & CEO | P Buy | 2026-03-13 | 2026-03-16 | 18,500 | $28.41 | $525.6K | 486,777 | SEC↗ |
| Hawryluk P. Kent | President & CEO | M Exercise deriv | 2026-02-26 | 2026-02-27 | 28,768 | — | $0 | 91,668 | SEC↗ |
| Hawryluk P. Kent | President & CEO | M Exercise | 2026-02-26 | 2026-02-27 | 28,768 | $16.00 | $460.3K | 728,274 | SEC↗ |
| Hawryluk P. Kent | President & CEO | A Award deriv | 2026-02-02 | 2026-02-03 | 164,500 | — | $0 | 164,500 | SEC↗ |
| Bartram Richard | Chief Financial Officer | A Award deriv | 2026-02-02 | 2026-02-03 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Azoulay Salomon | Chief Medical Officer | A Award deriv | 2026-02-02 | 2026-02-03 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Hawryluk P. Kent | President & CEO | A Award | 2026-02-02 | 2026-02-03 | 35,250 | — | $0 | 699,506 | SEC↗ |
| Bartram Richard | Chief Financial Officer | A Award | 2026-02-02 | 2026-02-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Azoulay Salomon | Chief Medical Officer | A Award | 2026-02-02 | 2026-02-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Stelzer Laurie | Director | A Award deriv | 2026-01-20 | 2026-01-22 | 32,000 | — | $0 | 32,000 | SEC↗ |
| Hoerter Steven L. | Director | A Award deriv | 2025-11-22 | 2026-04-22 | 0 | — | $0 | 0 | SEC↗ |
| Hoerter Steven L. | Director | A Award deriv | 2025-11-22 | 2025-11-25 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Hoerter Steven L. | Director | A Award deriv | 2025-11-06 | 2026-04-22 | 33,751 | — | $0 | 33,751 | SEC↗ |
| Hoerter Steven L. | Director | A Award deriv | 2025-11-06 | 2025-11-07 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Hawryluk P. Kent | President & CEO | M Exercise deriv | 2025-10-24 | 2025-10-28 | 182,859 | — | $0 | 129,708 | SEC↗ |
| Hawryluk P. Kent | President & CEO | M Exercise | 2025-10-24 | 2025-10-28 | 182,859 | $3.25 | $594.3K | 664,256 | SEC↗ |
| Hawryluk P. Kent | President & CEO | P Buy | 2025-10-20 | 2025-10-21 | 20,000 | $13.64 | $272.8K | 468,277 | SEC↗ |
| Hoerter Steven L. | Director | P Buy | 2025-10-17 | 2025-10-20 | 20,000 | $13.25 | $265.0K | 20,000 | SEC↗ |
| FHMLS X, L.P. | 10% Owner | P Buy | 2025-09-26 | 2025-09-30 | 666,666 | $18.00 | $12.00M | 5,219,440 | SEC↗ |
| Pescovitz Ora H. | Director | A Award deriv | 2025-06-05 | 2025-06-06 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Heron Patrick J | Director, 10% Owner | A Award deriv | 2025-06-05 | 2025-06-06 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Ryder Steven | Director | A Award deriv | 2025-06-05 | 2025-06-06 | 16,000 | — | $0 | 16,000 | SEC↗ |
| CORNELIUS JAMES M | Director | A Award deriv | 2025-06-05 | 2025-06-06 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Aynechi Tiba | Director | A Award deriv | 2025-06-05 | 2025-06-06 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Hoerter Steven L. | Director | A Award deriv | 2025-06-05 | 2025-06-06 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Mathers Edward T | Director, 10% Owner | A Award deriv | 2025-06-05 | 2025-06-06 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Pescovitz Ora H. | Director | P Buy | 2025-04-08 | 2025-04-10 | 7,693 | $5.89 | $45.3K | 24,329 | SEC↗ |
| Hoerter Steven L. | Director | A Award deriv | 2025-04-07 | 2025-04-09 | 32,000 | — | $0 | 32,000 | SEC↗ |
| OrbiMed Genesis GP LLC | Director, 10% Owner | P Buy | 2025-02-18 | 2025-02-19 | 49,070 | $10.84 | $531.9K | 3,255,000 | SEC↗ |
| OrbiMed Genesis GP LLC | Director, 10% Owner | P Buy | 2025-02-18 | 2025-02-19 | 94,100 | $10.84 | $1.02M | 747,887 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | P Buy | 2025-02-18 | 2025-02-19 | 94,100 | $10.84 | $1.02M | 747,887 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | P Buy | 2025-02-18 | 2025-02-19 | 49,070 | $10.84 | $531.9K | 3,255,000 | SEC↗ |
| OrbiMed Genesis GP LLC | Director, 10% Owner | P Buy | 2025-02-14 | 2025-02-19 | 29,540 | $9.85 | $291.0K | 3,205,930 | SEC↗ |
| OrbiMed Genesis GP LLC | Director, 10% Owner | P Buy | 2025-02-14 | 2025-02-19 | 17,962 | $9.90 | $177.8K | 3,176,390 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | P Buy | 2025-02-14 | 2025-02-19 | 17,962 | $9.90 | $177.8K | 3,176,390 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | P Buy | 2025-02-14 | 2025-02-19 | 29,540 | $9.85 | $291.0K | 3,205,930 | SEC↗ |
| Hawryluk P. Kent | President & CEO | P Buy | 2025-02-04 | 2025-02-05 | 50,000 | $10.69 | $534.5K | 448,277 | SEC↗ |
| Hawryluk P. Kent | President & CEO | A Award deriv | 2025-02-03 | 2025-02-05 | 243,000 | — | $0 | 243,000 | SEC↗ |
| Bartram Richard | Chief Financial Officer | A Award deriv | 2025-02-03 | 2025-02-05 | 95,000 | — | $0 | 95,000 | SEC↗ |
| Azoulay Salomon | Chief Medical Officer | A Award deriv | 2025-02-03 | 2025-02-05 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Wellington Biomedical Innovati | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 16,666,666 | — | $0 | 0 | SEC↗ |
| Wellington Biomedical Innovati | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 4,854,368 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 12,372,634 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 4,854,368 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 19,587,284 | — | $0 | 0 | SEC↗ |
| Aynechi Tiba | Director | C Conversion deriv | 2024-09-16 | 2024-09-17 | 16,666,666 | — | $0 | 0 | SEC↗ |
| Hawryluk P. Kent | President & CEO | C Conversion deriv | 2024-09-16 | 2024-09-17 | 1,396,762 | — | $0 | 0 | SEC↗ |
| Hawryluk P. Kent | President & CEO | C Conversion deriv | 2024-09-16 | 2024-09-17 | 76,969 | — | $0 | 0 | SEC↗ |
| Hawryluk P. Kent | President & CEO | C Conversion deriv | 2024-09-16 | 2024-09-17 | 970,873 | — | $0 | 0 | SEC↗ |
| Hawryluk P. Kent | President & CEO | C Conversion deriv | 2024-09-16 | 2024-09-17 | 345,705 | — | $0 | 0 | SEC↗ |
| Hawryluk P. Kent | President & CEO | C Conversion deriv | 2024-09-16 | 2024-09-17 | 2,015,681 | — | $0 | 0 | SEC↗ |
| Heron Patrick J | Director, 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 18,922,852 | — | $0 | 0 | SEC↗ |
| Heron Patrick J | Director, 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 28,297,265 | — | $0 | 0 | SEC↗ |
| CORNELIUS JAMES M | Director | C Conversion deriv | 2024-09-16 | 2024-09-17 | 994,069 | — | $0 | 0 | SEC↗ |
| CORNELIUS JAMES M | Director | C Conversion deriv | 2024-09-16 | 2024-09-17 | 233,192 | — | $0 | 0 | SEC↗ |
| FHMLS X, L.P. | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 18,922,852 | — | $0 | 0 | SEC↗ |
| FHMLS X, L.P. | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 28,297,265 | — | $0 | 0 | SEC↗ |
| NEA Partners 17, L.P. | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 25,142,840 | — | $0 | 0 | SEC↗ |
| NEA Partners 17, L.P. | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 12,299,854 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 4,854,368 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 19,587,284 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 12,372,634 | — | $0 | 0 | SEC↗ |
| SANDELL SCOTT D | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 12,299,854 | — | $0 | 0 | SEC↗ |
| SANDELL SCOTT D | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 25,142,840 | — | $0 | 0 | SEC↗ |
| Yang Rick | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 12,299,854 | — | $0 | 0 | SEC↗ |
| Yang Rick | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 25,142,840 | — | $0 | 0 | SEC↗ |
| Walker Paul Edward | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 12,299,854 | — | $0 | 0 | SEC↗ |
| Walker Paul Edward | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 25,142,840 | — | $0 | 0 | SEC↗ |
| Makhzoumi Mohamad | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 12,299,854 | — | $0 | 0 | SEC↗ |
| Makhzoumi Mohamad | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 25,142,840 | — | $0 | 0 | SEC↗ |
| Florence Anthony A. Jr. | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 12,299,854 | — | $0 | 0 | SEC↗ |
| Florence Anthony A. Jr. | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 25,142,840 | — | $0 | 0 | SEC↗ |
| Chang Carmen | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 12,299,854 | — | $0 | 0 | SEC↗ |
| Chang Carmen | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 25,142,840 | — | $0 | 0 | SEC↗ |
| Behbahani Ali | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 12,299,854 | — | $0 | 0 | SEC↗ |
| Behbahani Ali | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 25,142,840 | — | $0 | 0 | SEC↗ |
| BASKETT FOREST | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 12,299,854 | — | $0 | 0 | SEC↗ |
| BASKETT FOREST | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 25,142,840 | — | $0 | 0 | SEC↗ |
| Mathers Edward T | Director, 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 25,142,840 | — | $0 | 0 | SEC↗ |
| Mathers Edward T | Director, 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-17 | 12,299,854 | — | $0 | 0 | SEC↗ |
| Wellington Biomedical Innovati | 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 403,787 | — | $0 | 1,790,122 | SEC↗ |
| Wellington Biomedical Innovati | 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 1,386,335 | — | $0 | 1,386,335 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 403,787 | — | $0 | 403,787 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 2,658,428 | — | $0 | 2,658,428 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | P Buy | 2024-09-16 | 2024-09-17 | 250,000 | $16.00 | $4.00M | 653,787 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | P Buy | 2024-09-16 | 2024-09-17 | 500,000 | $16.00 | $8.00M | 3,158,428 | SEC↗ |
| Aynechi Tiba | Director | C Conversion | 2024-09-16 | 2024-09-17 | 1,386,335 | — | $0 | 1,386,335 | SEC↗ |
| Aynechi Tiba | Director | P Buy | 2024-09-16 | 2024-09-17 | 750,000 | $16.00 | $12.00M | 2,136,335 | SEC↗ |
| Hawryluk P. Kent | President & CEO | C Conversion | 2024-09-16 | 2024-09-17 | 115,914 | — | $0 | 398,277 | SEC↗ |
| Hawryluk P. Kent | President & CEO | C Conversion | 2024-09-16 | 2024-09-17 | 283,846 | — | $0 | 481,397 | SEC↗ |
| Heron Patrick J | Director, 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 3,927,774 | — | $0 | 3,927,774 | SEC↗ |
| Heron Patrick J | Director, 10% Owner | P Buy | 2024-09-16 | 2024-09-17 | 625,000 | $16.00 | $10.00M | 4,552,774 | SEC↗ |
| CORNELIUS JAMES M | Director | C Conversion | 2024-09-16 | 2024-09-17 | 102,082 | — | $0 | 102,082 | SEC↗ |
| FHMLS X, L.P. | 10% Owner | P Buy | 2024-09-16 | 2024-09-17 | 625,000 | $16.00 | $10.00M | 4,552,774 | SEC↗ |
| FHMLS X, L.P. | 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 3,927,774 | — | $0 | 3,927,774 | SEC↗ |
| NEA Partners 17, L.P. | 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 1,023,103 | — | $0 | 1,023,103 | SEC↗ |
| NEA Partners 17, L.P. | 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 2,091,383 | — | $0 | 3,114,486 | SEC↗ |
| NEA Partners 17, L.P. | 10% Owner | P Buy | 2024-09-16 | 2024-09-17 | 500,000 | $16.00 | $8.00M | 3,614,486 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | P Buy | 2024-09-16 | 2024-09-17 | 250,000 | $16.00 | $4.00M | 653,787 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 403,787 | — | $0 | 403,787 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | P Buy | 2024-09-16 | 2024-09-17 | 500,000 | $16.00 | $8.00M | 3,158,428 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 2,658,428 | — | $0 | 2,658,428 | SEC↗ |
| SANDELL SCOTT D | 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 2,091,383 | — | $0 | 3,114,486 | SEC↗ |
| SANDELL SCOTT D | 10% Owner | P Buy | 2024-09-16 | 2024-09-17 | 500,000 | $16.00 | $8.00M | 3,614,486 | SEC↗ |
| SANDELL SCOTT D | 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 1,023,103 | — | $0 | 1,023,103 | SEC↗ |
| Yang Rick | 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 2,091,383 | — | $0 | 3,114,486 | SEC↗ |
| Yang Rick | 10% Owner | P Buy | 2024-09-16 | 2024-09-17 | 500,000 | $16.00 | $8.00M | 3,614,486 | SEC↗ |
| Yang Rick | 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 1,023,103 | — | $0 | 1,023,103 | SEC↗ |
| Walker Paul Edward | 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 2,091,383 | — | $0 | 3,114,486 | SEC↗ |
| Walker Paul Edward | 10% Owner | P Buy | 2024-09-16 | 2024-09-17 | 500,000 | $16.00 | $8.00M | 3,614,486 | SEC↗ |
| Walker Paul Edward | 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 1,023,103 | — | $0 | 1,023,103 | SEC↗ |
| Makhzoumi Mohamad | 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 2,091,383 | — | $0 | 3,114,486 | SEC↗ |
| Makhzoumi Mohamad | 10% Owner | P Buy | 2024-09-16 | 2024-09-17 | 500,000 | $16.00 | $8.00M | 3,614,486 | SEC↗ |
| Makhzoumi Mohamad | 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 1,023,103 | — | $0 | 1,023,103 | SEC↗ |
| Florence Anthony A. Jr. | 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 2,091,383 | — | $0 | 3,114,486 | SEC↗ |
| Florence Anthony A. Jr. | 10% Owner | P Buy | 2024-09-16 | 2024-09-17 | 500,000 | $16.00 | $8.00M | 3,614,486 | SEC↗ |
| Florence Anthony A. Jr. | 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 1,023,103 | — | $0 | 1,023,103 | SEC↗ |
| Chang Carmen | 10% Owner | P Buy | 2024-09-16 | 2024-09-17 | 500,000 | $16.00 | $8.00M | 3,614,486 | SEC↗ |
| Chang Carmen | 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 2,091,383 | — | $0 | 3,114,486 | SEC↗ |
| Chang Carmen | 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 1,023,103 | — | $0 | 1,023,103 | SEC↗ |
| Behbahani Ali | 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 1,023,103 | — | $0 | 1,023,103 | SEC↗ |
| Behbahani Ali | 10% Owner | P Buy | 2024-09-16 | 2024-09-17 | 500,000 | $16.00 | $8.00M | 3,614,486 | SEC↗ |
| Behbahani Ali | 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 2,091,383 | — | $0 | 3,114,486 | SEC↗ |
| BASKETT FOREST | 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 2,091,383 | — | $0 | 3,114,486 | SEC↗ |
| BASKETT FOREST | 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 1,023,103 | — | $0 | 1,023,103 | SEC↗ |
| BASKETT FOREST | 10% Owner | P Buy | 2024-09-16 | 2024-09-17 | 500,000 | $16.00 | $8.00M | 3,614,486 | SEC↗ |
| Mathers Edward T | Director, 10% Owner | P Buy | 2024-09-16 | 2024-09-17 | 500,000 | $16.00 | $8.00M | 3,614,486 | SEC↗ |
| Mathers Edward T | Director, 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 2,091,383 | — | $0 | 3,114,486 | SEC↗ |
| Mathers Edward T | Director, 10% Owner | C Conversion | 2024-09-16 | 2024-09-17 | 1,023,103 | — | $0 | 1,023,103 | SEC↗ |
| Pescovitz Ora H. | Director | A Award deriv | 2024-09-12 | 2024-09-13 | 15,963 | — | $0 | 15,963 | SEC↗ |
| CORNELIUS JAMES M | Director | A Award deriv | 2024-09-12 | 2024-09-13 | 15,963 | — | $0 | 15,963 | SEC↗ |
| Heron Patrick J | Director, 10% Owner | A Award deriv | 2024-09-12 | 2024-09-13 | 15,963 | — | $0 | 15,963 | SEC↗ |
| Aynechi Tiba | Director | A Award deriv | 2024-09-12 | 2024-09-13 | 15,963 | — | $0 | 15,963 | SEC↗ |
| Hawryluk P. Kent | President & CEO | A Award deriv | 2024-09-12 | 2024-09-13 | 120,436 | — | $0 | 120,436 | SEC↗ |
| Mathers Edward T | Director, 10% Owner | A Award deriv | 2024-09-12 | 2024-09-13 | 15,963 | — | $0 | 15,963 | SEC↗ |
| Azoulay Salomon | Chief Medical Officer | A Award deriv | 2024-09-12 | 2024-09-13 | 45,011 | — | $0 | 45,011 | SEC↗ |
| Bartram Richard | Chief Financial Officer | A Award deriv | 2024-09-12 | 2024-09-13 | 42,578 | — | $0 | 42,578 | SEC↗ |
| Ryder Steven | Director | A Award deriv | 2024-09-12 | 2024-09-13 | 15,963 | — | $0 | 15,963 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | A Award deriv | 2024-09-12 | 2024-09-13 | 15,963 | — | $0 | 15,963 | SEC↗ |